{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:37:56Z","timestamp":1778024276085,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T00:00:00Z","timestamp":1708128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11096-024-01700-6","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T11:02:27Z","timestamp":1708167747000},"page":"656-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antipsychotic prescribing and drug-related readmissions in multimorbid older inpatients: a post-hoc analysis of the OPERAM population"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-5230","authenticated-orcid":false,"given":"A.","family":"Bienfait","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lagreula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Rodondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. T. G. M.","family":"Sallevelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"O\u2019Mahony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Spinewine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Dalleur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,17]]},"reference":[{"issue":"1","key":"1700_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1586\/17512433.2015.974557","volume":"8","author":"A McKean","year":"2015","unstructured":"McKean A, Monasterio E. Indications of atypical antipsychotics in the elderly. Expert Rev Clin Pharmacol. 2015;8(1):5\u20137.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1700_CR2","unstructured":"University SECaB. Patterns of medication use in the United States 2006, A report from the Slone survey. 2006. [cited 2021 April]; Available from https:\/\/www.bu.edu\/slone\/files\/2012\/11\/SloneSurveyReport2006.pdf"},{"issue":"1","key":"1700_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2050-6511-14-10","volume":"14","author":"M Gustafsson","year":"2013","unstructured":"Gustafsson M, Karlsson S, L\u00f6vheim H. Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. BMC Pharmacol Toxicol. 2013;14(1):1\u20138.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"6","key":"1700_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00228-017-2225-3","volume":"73","author":"TJ Oscanoa","year":"2017","unstructured":"Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta analysis. Eur J Clin Pharmacol. 2017;73(6):759\u201370.","journal-title":"Eur J Clin Pharmacol"},{"key":"1700_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12603-009-0237-0","volume":"14","author":"A Somers","year":"2010","unstructured":"Somers A, Robays H, Vander Stichele R, et al. Contribution of drug related problems to hospital admission in the elderly. J Nutr, Health Aging. 2010;14:477\u201382.","journal-title":"J Nutr, Health Aging"},{"issue":"4","key":"1700_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1445-5994.2001.00044.x","volume":"31","author":"M Chan","year":"2001","unstructured":"Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31(4):199\u2013205.","journal-title":"Intern Med J"},{"issue":"11","key":"1700_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2165\/11316750-000000000-00000","volume":"26","author":"S Rogers","year":"2009","unstructured":"Rogers S, Wilson D, Wan S, et al. Medication-related admissions in older people: a cross-sectional, observational study. Drugs Aging. 2009;26(11):951\u201361.","journal-title":"Drugs Aging"},{"key":"1700_CR8","doi-asserted-by":"crossref","unstructured":"The American Geriatrics Society Beers Criteria Update Expert P. American geriatrics society 2019 updated AGS Beers criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019; 67(4):674\u201394.","DOI":"10.1111\/jgs.15767"},{"issue":"4","key":"1700_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","volume":"14","author":"D O'Mahony","year":"2023","unstructured":"O\u2019Mahony D, Cherubini A, Guiteras AR, et al. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med. 2023;14(4):625\u201332.","journal-title":"Eur Geriatr Med"},{"key":"1700_CR10","doi-asserted-by":"publisher","first-page":"1009485","DOI":"10.3389\/fphar.2022.1009485","volume":"13","author":"S Park","year":"2022","unstructured":"Park S, Kim AJ, Ah YM, et al. Prevalence and predictors of medication-related emergency department visit in older adults: a multicenter study linking national claim database and hospital medical records. Front Pharmacol. 2022;13:1009485.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1700_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1474-4422(08)70295-3","volume":"8","author":"C Ballard","year":"2009","unstructured":"Ballard C, Hanney ML, Theodoulou M, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009;8(2):151\u20137.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1700_CR12","doi-asserted-by":"publisher","first-page":"e01008","DOI":"10.1002\/prp2.1008","volume":"10","author":"AS Doherty","year":"2022","unstructured":"Doherty AS, Shahid F, Moriarty F, et al. Prescribing cascades in community-dwelling adults: a systematic review. Pharmacol Res Perspect. 2022;10(5):e01008.","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"1700_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/ageing\/afx147","volume":"47","author":"A Renom-Guiteras","year":"2018","unstructured":"Renom-Guiteras A, Thurmann PA, Miralles R, et al. Potentially inappropriate medication among people with dementia in eight European countries. Age Ageing. 2018;47(1):68\u201374.","journal-title":"Age Ageing"},{"key":"1700_CR14","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2147\/CIA.S218641","volume":"14","author":"AM Bargagli","year":"2019","unstructured":"Bargagli AM, Cascini S, Agabiti N, et al. Determinants Of antipsychotic drugs prescription among community-living older adults with dementia: a population-based study using health information systems in the Lazio region. Italy Clin Interv Aging. 2019;14:2071\u201383.","journal-title":"Italy Clin Interv Aging"},{"issue":"7","key":"1700_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jagp.2017.02.013","volume":"25","author":"KJ Stock","year":"2017","unstructured":"Stock KJ, Hogan DB, Lapane K, et al. Antipsychotic use and hospitalization among older assisted living residents: does risk vary by frailty status? Am J Geriatr Psychiatry. 2017;25(7):779\u201390.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"7","key":"1700_CR16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00228-011-0996-5","volume":"67","author":"M Rikala","year":"2011","unstructured":"Rikala M, Korhonen MJ, Sulkava R, et al. Psychotropic drug use in community-dwelling elderly people-characteristics of persistent and incident users. Eur J Clin Pharmacol. 2011;67(7):731\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"1700_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40266-022-00947-w","volume":"39","author":"E Sonnerstam","year":"2022","unstructured":"Sonnerstam E, Gustafsson M, Lovheim H, et al. Potentially inappropriate medications pre-and post-diagnosis of major neurocognitive disorders among older people in Sweden: a register-based, 6-year longitudinal study. Drugs Aging. 2022;39(7):573\u201385.","journal-title":"Drugs Aging"},{"issue":"9","key":"1700_CR18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1177\/02698811221104055","volume":"36","author":"S Oh","year":"2022","unstructured":"Oh S, Byeon SJ, Chung SJ. Characteristics of adverse reactions among antipsychotic drugs using the Korean adverse event reporting system database from 2010 to 2019. J Psychopharmacol. 2022;36(9):1041\u201350.","journal-title":"J Psychopharmacol"},{"issue":"6","key":"1700_CR19","doi-asserted-by":"publisher","first-page":"e026769","DOI":"10.1136\/bmjopen-2018-026769","volume":"9","author":"L Adam","year":"2019","unstructured":"Adam L, Moutzouri E, Baumgartner C, et al. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019;9(6):e026769.","journal-title":"BMJ Open"},{"key":"1700_CR20","doi-asserted-by":"publisher","first-page":"n1585","DOI":"10.1136\/bmj.n1585","volume":"374","author":"MR Blum","year":"2021","unstructured":"Blum MR, Sallevelt B, Spinewine A, et al. Optimizing therapy to prevent avoidable hospital admissions in multimorbid older adults (OPERAM): cluster randomised controlled trial. BMJ. 2021;374:n1585.","journal-title":"BMJ"},{"key":"1700_CR21","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the barthel index. Md State Med J. 1965;14:61\u20135.","journal-title":"Md State Med J"},{"key":"1700_CR22","unstructured":"WHO. Defined daily dose (DDD)-definition and general considerations. [cited 2021 April]; Available from: https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd."},{"key":"1700_CR23","unstructured":"World Health Organization, The use of the WHO-UMC system for standardised case causality assessment. 2013. [cited 2021 April]; Available from: https:\/\/www.who.int\/publications\/m\/item\/WHO-causality-assessment"},{"issue":"11","key":"1700_CR24","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1111\/bcp.13716","volume":"84","author":"S Thevelin","year":"2018","unstructured":"Thevelin S, Spinewine A, Beuscart JB, et al. Development of a standardized chart review method to identify drug-related hospital admissions in older people. Br J Clin Pharmacol. 2018;84(11):2600\u201314.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"1700_CR25","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1111\/j.1532-5415.2011.03660.x","volume":"59","author":"Y Rhee","year":"2011","unstructured":"Rhee Y, Csernansky JG, Emanuel LL, et al. Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia. J Am Geriatr Soc. 2011;59(11):2100\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1700_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/PTS.0000000000000235","volume":"16","author":"M Sakuma","year":"2020","unstructured":"Sakuma M, Kanemoto Y, Furuse A, et al. Frequency and severity of adverse drug events by medication classes: the JADE study. J Patient Saf. 2020;16(1):30\u20135.","journal-title":"J Patient Saf"},{"issue":"12","key":"1700_CR27","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50(12):1962\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"1700_CR28","doi-asserted-by":"publisher","first-page":"41035","DOI":"10.1038\/srep41035","volume":"7","author":"CW Lin","year":"2017","unstructured":"Lin CW, Wen YW, Chen LK, et al. Potentially high-risk medication categories and unplanned hospitalizations: a case-time-control study. Sci Rep. 2017;7:41035.","journal-title":"Sci Rep"},{"issue":"10","key":"1700_CR29","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1176\/appi.ajp.160.10.1817","volume":"160","author":"LA Copeland","year":"2003","unstructured":"Copeland LA, Zeber JE, Valenstein M, et al. Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry. 2003;160(10):1817\u201322.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1700_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4103\/0019-5154.110832","volume":"58","author":"MK Church","year":"2013","unstructured":"Church MK, Church DS. Pharmacology of antihistamines. Indian J Dermatol. 2013;58(3):219\u201324.","journal-title":"Indian J Dermatol"},{"issue":"12","key":"1700_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1524-6175.2005.05300.x","volume":"7","author":"DA Sica","year":"2005","unstructured":"Sica DA. Alpha1-adrenergic blockers: current usage considerations. J Clin Hypertens (Greenwich). 2005;7(12):757\u201362.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"1","key":"1700_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","volume":"15","author":"AR Moore","year":"1999","unstructured":"Moore AR, O\u2019Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15(1):15\u201328.","journal-title":"Drugs Aging"},{"issue":"10","key":"1700_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","volume":"27","author":"\u00d3 H\u00e1lfd\u00e1narson","year":"2017","unstructured":"H\u00e1lfd\u00e1narson \u00d3, Zo\u00ebga H, Aagaard L, et al. International trends in antipsychotic use: a study in 16 countries, 2005\u20132014. Eur Neuropsychopharmacol. 2017;27(10):1064\u201376.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"1700_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1365-2125.2003.01875.x","volume":"57","author":"PA Routledge","year":"2004","unstructured":"Routledge PA, O\u2019Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57(2):121\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1700_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2165\/00002512-199914020-00005","volume":"14","author":"PA Atkin","year":"1999","unstructured":"Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging. 1999;14(2):141\u201352.","journal-title":"Drugs Aging"},{"issue":"4","key":"1700_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.29252\/beat-070401","volume":"7","author":"MB Ayalew","year":"2019","unstructured":"Ayalew MB, Tegegn HG, Abdela OA. Drug related hospital admissions; a systematic review of the recent literatures. Bull Emerg Trauma. 2019;7(4):339\u201346.","journal-title":"Bull Emerg Trauma"},{"issue":"2","key":"1700_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.genhosppsych.2006.12.002","volume":"29","author":"JM Rothschild","year":"2007","unstructured":"Rothschild JM, Mann K, Keohane CA, et al. Medication safety in a psychiatric hospital. Gen Hosp Psychiatry. 2007;29(2):156\u201362.","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"1700_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O'Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, et al. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138.","journal-title":"Age Ageing"},{"issue":"5","key":"1700_CR39","doi-asserted-by":"publisher","first-page":"394","DOI":"10.2146\/ajhp130221","volume":"71","author":"SL Anderson","year":"2014","unstructured":"Anderson SL, Vande Griend JP. Quetiapine for insomnia: a review of the literature. Am J Health-Syst Pharm. 2014;71(5):394\u2013402.","journal-title":"Am J Health-Syst Pharm"},{"issue":"5","key":"1700_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.5664\/jcsm.27286","volume":"4","author":"S Schutte-Rodin","year":"2008","unstructured":"Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4(5):487\u2013504.","journal-title":"J Clin Sleep Med"},{"key":"1700_CR41","first-page":"1363","volume":"9","author":"P Gareri","year":"2014","unstructured":"Gareri P, Segura-Garcia C, Manfredi VG, et al. Use of atypical antipsychotics in the elderly: a clinical review. Clin Interv Aging. 2014;9:1363\u201373.","journal-title":"Clin Interv Aging"},{"issue":"5","key":"1700_CR42","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s11096-023-01630-9","volume":"45","author":"J Howe","year":"2023","unstructured":"Howe J, Lindsey L. The role of pharmacists in supporting service users to optimise antipsychotic medication. Int J Clin Pharm. 2023;45(5):1293\u20138.","journal-title":"Int J Clin Pharm"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01700-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T14:40:59Z","timestamp":1716907259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01700-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,17]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1700"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01700-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3268091\/v1","asserted-by":"object"}]},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,17]]},"assertion":[{"value":"16 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}